Close Menu

Director, Global Health Economics & Outcomes Research (GHEOR)

Organization
Agilent
Job Location
5301 Stevens Creek Blvd
Santa Clara, CA 95051
United States
Job Description

Agilent is looking to expand its team, which includes a diverse set of Clinical and Medical affairs experts! We are seeking a Health Economist to provide scientific and programming expertise for the development of applied economic evaluations to accompany our rigorous reviews of scientific evidence!

You will work closely with DGG solutions units/divisions and sales teams to ensure access is a planned and integral part of the pipeline development and commercialization stages of our products, starting at the earliest points of a molecule's life-cycle and going up to and beyond its launch. A key element of this work is ensuring we create the necessary evidence packages required to demonstrate the utility and economic value our products deliver to payers, clinicians, patients, their families, and society.

You will have responsibility for identification, demonstration, and evaluation of the impact of the life cycle indications and value propositions and will lead all aspects of global health economic strategy, including pricing throughout the product lifecycle. You will deliver clear recommendations for payer strategies, evidence generation, including data collections and economic value proposition.

The health economist will also lead, on a project basis, the development and specification of a budgetary impact model that will be based in part on inputs received from the Medical and Clinical Affairs collaborators from Agilent and external Pharmaceutical partnerships.

In addition, the role will involve explicitly conceptualizing, specifying, and testing economic models developed internally at Agilent to assess the potential costs, cost-effectiveness and/or budgetary impact of a wide range of diagnostic, prognostic, therapeutic and other clinical interventions.

  • You will collaborate with cross-functional teams to develop real-world evidence strategies and tactics to support medical teams and access to appropriate therapeutic options.
  • Developing and maintaining an in-depth understanding of Oncology therapeutic area strategies, disease areas, relevant clinical, patient, payer, and reimbursement landscapes.
  • Comprehensive evidence generation strategies including health economic and outcomes research (HEOR) as well as health systems' research to support the value demonstration of assets pre-launch and/or marketed products in relevant disease/ therapeutic areas.
  • Demonstrate the health economic, humanistic, and health systems' value and benefit of Pharmaceutical Partners's products.
  • Develop and flawlessly execute studies (e.g., burden of illness studies, treatment patterns, quality of care etc.).
  • Find opportunities to partner with external customers to conduct HEOR projects in support of asset and therapeutic area strategies.
  • Design, develop, conduct and lead HEOR studies for assigned product(s) and indications(s).
  • Develop, maintain and apply in-depth knowledge of role, disease state and clinical topics, market/customer landscape and emerging issues.
  • Proactively collaborate with various functions within and outside of US Clinical and Medical Affairs to ensure alignment of activities with key partners and stakeholders.
  • Attend customer and other external meetings to advance learning, build relationships and demonstrate Pharmaceutical Partner's value.

Participate in all required Pharmaceutical Partners and HEOR training and development programs

Requirements

Qualifications

  • Masters Degree (health economics, epidemiology, life sciences, public health, health services research); Doctoral Degree in above or other related disciplines
  • 8+ years of experience in relevant health economics and outcomes research fields, one of which are part of a health economics and/or outcomes research team in a pharmaceutical company
  • Knowledge of biometrics, biostatistics, clinical research and development methods, epidemiology, decision analytical modeling, marketing, payers and formulary processes/practices
  • Understanding of the U.S., healthcare landscape
  • Knowledge of relevant health economics strategy development, HEOR methodologies and modeling (quantitative and qualitative)
  • Strong working knowledge of the technical and methodological aspects of observational study design and implementation
  • Strong methodological skills (pharmacoeconomic modeling, study design, data analysis and interpretation) in epidemiology or health services research
  • Excellent written and oral communication skills
  • Strong project management abilities (contracting, budgeting, vendor management) crucial
  • Demonstrated ability to lead multiple projects involving complex processes, challenging deadlines and rapidly shifting priorities
  • Knowledge of overall drug development, medical affairs, and post-marketing planning relevant to pharmaceutical/biotechnology organizations
  • Skilled in functioning within a matrix organization where leading through influence is required
  • Business travel by air or car

Preferred:

  • 3+ years' experience developing health-focused econometric models using decision- analysis software (e.g., TreeAge, advanced Excel)
  • Experience with interactive application programming languages (e.g., VisualBasic, Java, ColdFusion) helpful

A new report finds that women, especially women of color, are missing among the high-earners at research universities in the US, the Chronicle of Higher Education writes. 

Researcher-parents, especially mothers of small children, have lost research time during the COVID-19 pandemic, according to the Chronicle of Higher Education.

Inside Higher Ed reports that the preprint site medRxiv has taken off with the COVID-19 pandemic.

Inside Higher Ed reports some university professors are pushing back against plans for increased numbers of in-person classes for next semester.